Supplementary Material Study Sample the Vervets Used in This

Total Page:16

File Type:pdf, Size:1020Kb

Supplementary Material Study Sample the Vervets Used in This Supplementary Material Study sample The vervets used in this study are part of a pedigreed research colony that has included more than 2,000 monkeys since its founding. Briefly, the Vervet Research Colony (VRC) was established at UCLA during the 1970’s and 1980’s from 57 founder animals captured from wild populations on the adjacent Caribbean islands of St. Kitts and Nevis; Europeans brought the founders of these populations to the Caribbean from West Africa in the 17th Century 1. The breeding strategy of the VRC has emphasized the promotion of diversity, the preservation of the founding matrilines, and providing all females and most of the males an opportunity to breed. The colony design modeled natural vervet social groups to facilitate behavioral investigations in semi-natural conditions. Social groups were housed in large outdoor enclosures with adjacent indoor shelters. Each enclosure had chain link siding that provided visual access to the outside, with one or two large sitting platforms and numerous shelves, climbing structures and enrichments devices. The monkeys studied were members of 16 different social matrilineal groups, containing from 15 to 46 members per group. In 2008 the VRC was moved to Wake Forest School of Medicine’s Center for Comparative Medicine Research, however the samples for gene expression measurements in Dataset 1 (see below) and the MRI assessments used in this study occurred when the colony was at UCLA. Gene expression phenotypes Two sets of gene expression measurements were collected. Dataset 1 used RNA obtained from whole blood in 347 vervets, assayed by microarray (Illumina HumanRef-8 v2); Dataset 2 assayed gene expression by RNA-Seq, in RNA obtained from 58 animals, with seven tissues (adrenal, blood, Brodmann area 46 [BA46], caudate, fibroblast, hippocampus and pituitary) measured in each animal. Dataset 1: Microarray (blood) The microarray data set has been described in Jasinska et al. 2 and is available at NCBI at the BioProject PRJNA115831. Briefly, Total RNA from whole blood preserved in PaxGene RNA Blood tubes (PreAnalyticX) was extracted using PAXgene Blood RNA Kit (PreAnalyticX). The integrity of the extracted total RNA samples was assessed on the Agilent 2100 Bioanalyzer (Agilent Technologies) with the RNA 6000 Nano Assay Kit (Agilent Technologies), and sample concentrations were quantified with RiboGreen RNA (Invitrogen). For assessing transcript levels, we used the Illumina HumanRef-8 v2 chip. This chip provides genome-wide transcriptional coverage of well-characterized genes and splice variants. This chip uses 22,184 probes representing 18,189 unique human genes (or 20,424 unique transcripts) from Reference Sequence (RefSeq) database1, Release 17. The Illumina gene expression platform utilizes 50-mer gene-specific probes that provide both good selectivity and sensitivity 3. We expected that the long probes would also tolerate sequence incompatibilities between human probe sequence and vervet target transcripts and be more robust than shorter probes to possible allelo-specific differences in hybridization efficiency due to vervet-specific SNP variants occurring in probe-interaction sites 4. cDNA was synthesized and in vitro transcribed into biotinylated cRNA using the Illumina Totalprep RNA amplification kit, following the manufacturer’s instructions (Ambion). Labeled cRNA was hybridized to the HumanRef-8 version 2 (Illumina) gene expression bead-chip. A gene was called detectable by BeadStudio when the detection p-value was <0.01. The gene expression module of the BeadStudio software version 3.1 (Illumina) was used for initial data processing and background correction. Lumi software was also used to perform a variance-stabilizing transformation that takes advantage of the technical replicates available on every Illumina microarray (usually over 30 randomly distributed beads per probe), and subsequently performs robust spline normalization and quality control of gene expression measures 5. Probe filtering for eQTL analysis: The probes on the Illumina HumanRef-8 v2 microarray were originally developed for assaying gene expression in humans. We selected probes that were compatible with vervet genomic sequence based on the following criteria: contain no indels, up a total of five mismatches in a probe, with maximum of one mismatch in the 16 nt central portion of the probe). To prevent expression measurement-bias due to SNP interference with the hybridization process, we excluded probes targeting sequences with high-quality common SNPs identified in the VRC pedigree. For this filtering step, we used a set of 3.45 Mln high-quality SNPs segregating in the VRC with MAF>=10%. A total of 11,001 probes passed these filters (Supplementary Data 1). We then evaluated the detection levels of each probe in all animals, and retained for analysis 6,018 probes that were detected with Illumina p<0.05 in at least 5% of animals. Dataset 2: RNA-Seq (seven tissues) Below we describe sample collection and processing, and determination of expression counts for the RNA-Seq gene expression dataset. Tissue collection for RNA: Tissues were obtained from 60 vervets during experimental necropsies. The vervets represented a range of developmental stages from neonates (7 days), infants (90 days and one year), young juveniles (1.25, 1.5, 1.75, 2 years old), peri- adolescents or subadults (2.5, 3 years old) to adults (4+ years old) with 6 vervets (3 males and 3 females) from each developmental time point. Two animals (a 1.75 year old female and a 7 day old male) were excluded for the eQTL study as they did not have WGS data, leaving a total of 58 monkeys with RNA-Seq and whole genome sequencing (WGS) data for eQTL analysis. Two samples (from caudate and BA46) from individual 2008147 were excluded after the PCA analysis suggested a sample mix-up between tissues. Vervets were anesthetized with 10-15 mg/kg of ketamine administered intramuscularly followed by pentobarbital 100 mg/kg administered intravenously. After animals reached a deep plane of anesthesia, the abdominal and thoracic cavities were opened and the vasculature was perfused with normal saline chilled to 4 C administered via the left cardiac ventricle until perfusate escaping through a cut in the○ inferior vena cava became blood free. After exsanguination, the head was then disarticulated and the top of the cranium removed using Ronjeurs to chip off small bone pieces. Keeping the Ronjeurs superficial to the dura, bone was first removed at the base of the skull, proceeding anteriorly just above the ear canal and across the brow ridge to fully encircle the entire head. The dura was then cut with scissors, and the top of the skull was removed with Ronjeurs. Scissors were used to cut cranial nerves II-XII to free the brain, keeping the olfactory nerve and olfactory bulb together with the brain when possible. After removal, the brain was weighed, and then hemisected with a scalpel. The right hemisphere was preserved in 10% neutral buffered formalin and the left hemisphere was dissected. Brain tissues were generally collected within 60-70 minutes of removal of the brain from the skull. All brain samples were placed immediately in RNAlater and refrigerated for 24 hours. The RNAlater was then removed and the tissue frozen at -80 C or below. ○ For 14 necropsies performed after August 4, 2010, the necropsy protocol was modified as follows: 1) 100% oxygen was delivered to the animal by face mask starting before pentobarbital administration and continuing until initiation of saline perfusion; 2) the animal was placed on a bed of ice prior to pentobarbital administration (but after ketamine administration) to accelerate cooling of tissues; 3) dissection protocols were streamlined to minimize the time elapsed between pentobarbital administration and removal of the brain from the skull and to minimize the time elapsed to the completion of brain dissection. During necropsies of 30 vervets whose brain tissues were used in this study, a fresh frozen sample of occipital lobe was collected near the end of the dissection procedure to allow tissue pH to be measured. pH was measured in occipital lobe specimens as described by Harrison et al.6. pH ranged from 5.98 to 6.98 (mean pH 6.6, SD 0.2). These data were used to assess the potential effect of brain pH on gene expression PC patterns (see Possible Technical and Biological Covariates). BA46: The samples were collected from both banks of the principal sulcus, bluntly dissecting downward with forceps inserted at the upper margin of each bank to free tissue to the floor of the principal sulcus. The midpoint of the principal sulcus along its length was used as the posterior margin for the collected samples, which extended anteriorly for the length of the sulcus. The samples collected from the two sulcal banks were pooled at the time of dissection and processed as a single sample. Caudate: From the medial surface of the hemisected brain, forceps were inserted into the lateral ventricle and used to remove the overlying tissue, exposing the caudate. A coronally oriented cut was then made through the head of the caudate, and caudate tissue was pinched from the portion of the brain anterior to this cut using forceps. Hippocampus: To obtain the hippocampal sample, a coronally oriented cut was made with a scalpel through the occipital pole, passing through the head and body of the hippocampus. Blunt dissection with forceps was used to isolate the hippocampus from surrounding tissue, extending approximately 2-3 mm into the exposed tissue face. RNA collection: The following tissue preservation methods were used during the collection to maintain sample quality. Whole blood was drawn into PAXgene RNA Blood Tubes (PreAnalyticX) with reagent instantly stabilizing RNA profiles. Solid tissues were preserved in RNAlater reagent (Ambion) immediately after collection, protecting the integrity of RNA profiles. To establish fibroblast cultures, skin biopsies were collected from shaved and cleaned skin from an area of the middle of the thigh (outer side) using a skin punch, after ketamine anesthesia but prior to euthanasia.
Recommended publications
  • Download (PDF)
    ANALYTICAL SCIENCES NOVEMBER 2020, VOL. 36 1 2020 © The Japan Society for Analytical Chemistry Supporting Information Fig. S1 Detailed MS/MS data of myoglobin. 17 2 ANALYTICAL SCIENCES NOVEMBER 2020, VOL. 36 Table S1 : The protein names (antigens) identified by pH 2.0 solution in the eluted-fraction. These proteins were identified one or more out of six analyses. Accession Description P08908 5-hydroxytryptamine receptor 1A OS=Homo sapiens GN=HTR1A PE=1 SV=3 - [5HT1A_HUMAN] Q9NRR6 72 kDa inositol polyphosphate 5-phosphatase OS=Homo sapiens GN=INPP5E PE=1 SV=2 - [INP5E_HUMAN] P82987 ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 - [ATL3_HUMAN] Q9Y6K8 Adenylate kinase isoenzyme 5 OS=Homo sapiens GN=AK5 PE=1 SV=2 - [KAD5_HUMAN] P02763 Alpha-1-acid glycoprotein 1 OS=Homo sapiens GN=ORM1 PE=1 SV=1 - [A1AG1_HUMAN] P19652 Alpha-1-acid glycoprotein 2 OS=Homo sapiens GN=ORM2 PE=1 SV=2 - [A1AG2_HUMAN] P01011 Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=2 - [AACT_HUMAN] P01009 Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 - [A1AT_HUMAN] P04217 Alpha-1B-glycoprotein OS=Homo sapiens GN=A1BG PE=1 SV=4 - [A1BG_HUMAN] P08697 Alpha-2-antiplasmin OS=Homo sapiens GN=SERPINF2 PE=1 SV=3 - [A2AP_HUMAN] P02765 Alpha-2-HS-glycoprotein OS=Homo sapiens GN=AHSG PE=1 SV=1 - [FETUA_HUMAN] P01023 Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 - [A2MG_HUMAN] P01019 Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 - [ANGT_HUMAN] Q9NQ90 Anoctamin-2 OS=Homo sapiens GN=ANO2 PE=1 SV=2 - [ANO2_HUMAN] P01008 Antithrombin-III
    [Show full text]
  • Genetic Screens in Isogenic Mammalian Cell Lines Without Single Cell Cloning
    ARTICLE https://doi.org/10.1038/s41467-020-14620-6 OPEN Genetic screens in isogenic mammalian cell lines without single cell cloning Peter C. DeWeirdt1,2, Annabel K. Sangree1,2, Ruth E. Hanna1,2, Kendall R. Sanson1,2, Mudra Hegde 1, Christine Strand 1, Nicole S. Persky1 & John G. Doench 1* Isogenic pairs of cell lines, which differ by a single genetic modification, are powerful tools for understanding gene function. Generating such pairs of mammalian cells, however, is labor- 1234567890():,; intensive, time-consuming, and, in some cell types, essentially impossible. Here, we present an approach to create isogenic pairs of cells that avoids single cell cloning, and screen these pairs with genome-wide CRISPR-Cas9 libraries to generate genetic interaction maps. We query the anti-apoptotic genes BCL2L1 and MCL1, and the DNA damage repair gene PARP1, identifying both expected and uncharacterized buffering and synthetic lethal interactions. Additionally, we compare acute CRISPR-based knockout, single cell clones, and small- molecule inhibition. We observe that, while the approaches provide largely overlapping information, differences emerge, highlighting an important consideration when employing genetic screens to identify and characterize potential drug targets. We anticipate that this methodology will be broadly useful to comprehensively study gene function across many contexts. 1 Genetic Perturbation Platform, Broad Institute of MIT and Harvard, 75 Ames Street, Cambridge, MA 02142, USA. 2These authors contributed equally: Peter C. DeWeirdt,
    [Show full text]
  • Release Β ATP-Induced IL-1 and Canonical Nicotinic Agonists Inhibit Phosphocholine-Modified Macromolecules
    Phosphocholine-Modified Macromolecules and Canonical Nicotinic Agonists Inhibit ATP-Induced IL-1β Release This information is current as Andreas Hecker, Mira Küllmar, Sigrid Wilker, Katrin of September 24, 2021. Richter, Anna Zakrzewicz, Srebrena Atanasova, Verena Mathes, Thomas Timm, Sabrina Lerner, Jochen Klein, Andreas Kaufmann, Stefan Bauer, Winfried Padberg, Wolfgang Kummer, Sabina Janciauskiene, Martin Fronius, Elke K. H. Schweda, Günter Lochnit and Veronika Grau Downloaded from J Immunol 2015; 195:2325-2334; Prepublished online 22 July 2015; doi: 10.4049/jimmunol.1400974 http://www.jimmunol.org/content/195/5/2325 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2015/07/22/jimmunol.140097 Material 4.DCSupplemental References This article cites 42 articles, 11 of which you can access for free at: http://www.jimmunol.org/content/195/5/2325.full#ref-list-1 by guest on September 24, 2021 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]
  • Molecular Mechanisms Involved Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2010 Molecular Mechanisms Involved Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis Ryan Fassnacht Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Physiology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2246 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Ryan C. Fassnacht 2010 All Rights Reserved Molecular Mechanisms Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University. by Ryan Christopher Fassnacht, B.S. Hampden Sydney University, 2005 M.S. Virginia Commonwealth University, 2010 Director: Valeria Mas, Ph.D., Associate Professor of Surgery and Pathology Division of Transplant Department of Surgery Virginia Commonwealth University Richmond, Virginia July 9, 2010 Acknowledgement The Author wishes to thank his family and close friends for their support. He would also like to thank the members of the molecular transplant team for their help and advice. This project would not have been possible with out the help of Dr. Valeria Mas and her endearing
    [Show full text]
  • List of Genes Used in Cell Type Enrichment Analysis
    List of genes used in cell type enrichment analysis Metagene Cell type Immunity ADAM28 Activated B cell Adaptive CD180 Activated B cell Adaptive CD79B Activated B cell Adaptive BLK Activated B cell Adaptive CD19 Activated B cell Adaptive MS4A1 Activated B cell Adaptive TNFRSF17 Activated B cell Adaptive IGHM Activated B cell Adaptive GNG7 Activated B cell Adaptive MICAL3 Activated B cell Adaptive SPIB Activated B cell Adaptive HLA-DOB Activated B cell Adaptive IGKC Activated B cell Adaptive PNOC Activated B cell Adaptive FCRL2 Activated B cell Adaptive BACH2 Activated B cell Adaptive CR2 Activated B cell Adaptive TCL1A Activated B cell Adaptive AKNA Activated B cell Adaptive ARHGAP25 Activated B cell Adaptive CCL21 Activated B cell Adaptive CD27 Activated B cell Adaptive CD38 Activated B cell Adaptive CLEC17A Activated B cell Adaptive CLEC9A Activated B cell Adaptive CLECL1 Activated B cell Adaptive AIM2 Activated CD4 T cell Adaptive BIRC3 Activated CD4 T cell Adaptive BRIP1 Activated CD4 T cell Adaptive CCL20 Activated CD4 T cell Adaptive CCL4 Activated CD4 T cell Adaptive CCL5 Activated CD4 T cell Adaptive CCNB1 Activated CD4 T cell Adaptive CCR7 Activated CD4 T cell Adaptive DUSP2 Activated CD4 T cell Adaptive ESCO2 Activated CD4 T cell Adaptive ETS1 Activated CD4 T cell Adaptive EXO1 Activated CD4 T cell Adaptive EXOC6 Activated CD4 T cell Adaptive IARS Activated CD4 T cell Adaptive ITK Activated CD4 T cell Adaptive KIF11 Activated CD4 T cell Adaptive KNTC1 Activated CD4 T cell Adaptive NUF2 Activated CD4 T cell Adaptive PRC1 Activated
    [Show full text]
  • Markers of T Cell Senescence in Humans
    International Journal of Molecular Sciences Review Markers of T Cell Senescence in Humans Weili Xu 1,2 and Anis Larbi 1,2,3,4,5,* 1 Biology of Aging Program and Immunomonitoring Platform, Singapore Immunology Network (SIgN), Agency for Science Technology and Research (A*STAR), Immunos Building, Biopolis, Singapore 138648, Singapore; [email protected] 2 School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore 3 Department of Microbiology, National University of Singapore, Singapore 117597, Singapore 4 Department of Geriatrics, Faculty of Medicine, University of Sherbrooke, Sherbrooke, QC J1K 2R1, Canada 5 Faculty of Sciences, University ElManar, Tunis 1068, Tunisia * Correspondence: [email protected]; Tel.: +65-6407-0412 Received: 31 May 2017; Accepted: 26 July 2017; Published: 10 August 2017 Abstract: Many countries are facing the aging of their population, and many more will face a similar obstacle in the near future, which could be a burden to many healthcare systems. Increased susceptibility to infections, cardiovascular and neurodegenerative disease, cancer as well as reduced efficacy of vaccination are important matters for researchers in the field of aging. As older adults show higher prevalence for a variety of diseases, this also implies higher risk of complications, including nosocomial infections, slower recovery and sequels that may reduce the autonomy and overall quality of life of older adults. The age-related effects on the immune system termed as “immunosenescence” can be exemplified by the reported hypo-responsiveness to influenza vaccination of the elderly. T cells, which belong to the adaptive arm of the immune system, have been extensively studied and the knowledge gathered enables a better understanding of how the immune system may be affected after acute/chronic infections and how this matters in the long run.
    [Show full text]
  • Recent Advances of M6a Methylation Modification in Esophageal Squamous Cell Carcinoma
    Zhang et al. Cancer Cell Int (2021) 21:421 https://doi.org/10.1186/s12935-021-02132-2 Cancer Cell International REVIEW Open Access Recent advances of m6A methylation modifcation in esophageal squamous cell carcinoma Xiaoqing Zhang1†, Ning Lu1†, Li Wang2†, Yixuan Wang1, Minna Li1, Ying Zhou3, Manli Cui1*, Mingxin Zhang1,3* and Lingmin Zhang4* Abstract In recent years, with the development of RNA sequencing technology and bioinformatics methods, the epigenetic modifcation of RNA based on N6-methyladenosine (m6A) has gradually become a research hotspot in the feld of bioscience. m6A is the most abundant internal modifcation in eukaryotic messenger RNAs (mRNAs). m6A methylation modifcation can dynamically and reversibly regulate RNA transport, localization, translation and degradation through the interaction of methyltransferase, demethylase and reading protein. m6A methylation can regulate the expression of proto-oncogenes and tumor suppressor genes at the epigenetic modifcation level to afect tumor occurrence and metastasis. The morbidity and mortality of esophageal cancer (EC) are still high worldwide. Esophageal squamous cell carcinoma (ESCC) is the most common tissue subtype of EC. This article reviews the related concepts, biological functions and recent advances of m6A methylation in ESCC, and looks forward to the prospect of m6A methylation as a new diagnostic biomarker and potential therapeutic target for ESCC. Keywords: N6-methyladenosine, Methylation, Esophageal squamous cell carcinoma Introduction surgical resection, combined radiotherapy and chemo- Esophageal cancer (EC) is one of the most invasive malig- therapy have improved the prognosis of patients with nant tumors of digestive tract in the world, and its mor- ESCC, the 5-year overall survival rate is still very low [5], bidity and mortality are still high in China [1].
    [Show full text]
  • Cognition and Steroidogenesis in the Rhesus Macaque
    Cognition and Steroidogenesis in the Rhesus Macaque Krystina G Sorwell A DISSERTATION Presented to the Department of Behavioral Neuroscience and the Oregon Health & Science University School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2013 School of Medicine Oregon Health & Science University CERTIFICATE OF APPROVAL This is to certify that the PhD dissertation of Krystina Gerette Sorwell has been approved Henryk Urbanski Mentor/Advisor Steven Kohama Member Kathleen Grant Member Cynthia Bethea Member Deb Finn Member 1 For Lily 2 TABLE OF CONTENTS Acknowledgments ......................................................................................................................................................... 4 List of Figures and Tables ............................................................................................................................................. 7 List of Abbreviations ................................................................................................................................................... 10 Abstract........................................................................................................................................................................ 13 Introduction ................................................................................................................................................................. 15 Part A: Central steroidogenesis and cognition ............................................................................................................
    [Show full text]
  • Human Β‑1,3‑Glucuronyltransferase 1/B3GAT1 Antibody Monoclonal Mouse Igg2a Clone # 1002707 Catalog Number: MAB8560
    Human β‑1,3‑Glucuronyltransferase 1/B3GAT1 Antibody Monoclonal Mouse IgG2A Clone # 1002707 Catalog Number: MAB8560 DESCRIPTION Species Reactivity Human Specificity Detects human β-1,3-Glucuronyltransferase 1/B3GAT1 in direct ELISAs. Source Monoclonal Mouse IgG2A Clone # 1002707 Purification Protein A or G purified from hybridoma culture supernatant Immunogen Chinese Hamster Ovary cell line, CHO-derived human β‑1,3‑Glucuronyltransferase 1/B3GAT1 His25-Ile334 Accession # Q9P2W7 Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. See Certificate of Analysis for details. *Small pack size (-SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS. APPLICATIONS Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website. Recommended Sample Concentration Immunohistochemistry 5-25 µg/mL See Below DATA Immunohistochemistry β-1,3-Glucuronyltransferase 1/B3GAT1 in Human Brain. β-1,3-Glucuronyltransferase 1/B3GAT1 was detected in immersion fixed paraffin-embedded sections of human brain (cortex) using Mouse Anti-Human β-1,3- Glucuronyltransferase 1/B3GAT1 Monoclonal Antibody (Catalog # MAB8560) at 5 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC001). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cytoplasm in neurons. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents. PREPARATION AND STORAGE Reconstitution Reconstitute at 0.5 mg/mL in sterile PBS.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • To Study Mutant P53 Gain of Function, Various Tumor-Derived P53 Mutants
    Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By Shama K Khokhar M.Sc., Bilaspur University, 2004 B.Sc., Bhopal University, 2002 2007 1 COPYRIGHT SHAMA K KHOKHAR 2007 2 WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES Date of Defense: 12-03-07 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY SHAMA KHAN KHOKHAR ENTITLED Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science Madhavi P. Kadakia, Ph.D. Thesis Director Daniel Organisciak , Ph.D. Department Chair Committee on Final Examination Madhavi P. Kadakia, Ph.D. Steven J. Berberich, Ph.D. Michael Leffak, Ph.D. Joseph F. Thomas, Jr., Ph.D. Dean, School of Graduate Studies 3 Abstract Khokhar, Shama K. M.S., Department of Biochemistry and Molecular Biology, Wright State University, 2007 Differential effect of TAp63γ mutants on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. p63, a member of the p53 gene family, known to play a role in development, has more recently also been implicated in cancer progression. Mice lacking p63 exhibit severe developmental defects such as limb truncations, abnormal skin, and absence of hair follicles, teeth, and mammary glands. Germline missense mutations of p63 have been shown to be responsible for several human developmental syndromes including SHFM, EEC and ADULT syndromes and are associated with anomalies in the development of organs of epithelial origin.
    [Show full text]
  • Understanding the Role of the Chromosome 15Q25.1 in COPD Through Epigenetics and Transcriptomics
    European Journal of Human Genetics (2018) 26:709–722 https://doi.org/10.1038/s41431-017-0089-8 ARTICLE Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics 1 1,2 1,3,4 5,6 5,6 Ivana Nedeljkovic ● Elena Carnero-Montoro ● Lies Lahousse ● Diana A. van der Plaat ● Kim de Jong ● 5,6 5,7 6 8 9 10 Judith M. Vonk ● Cleo C. van Diemen ● Alen Faiz ● Maarten van den Berge ● Ma’en Obeidat ● Yohan Bossé ● 11 1,12 12 1 David C. Nickle ● BIOS Consortium ● Andre G. Uitterlinden ● Joyce J. B. van Meurs ● Bruno C. H. Stricker ● 1,4,13 6,8 5,6 1 1 Guy G. Brusselle ● Dirkje S. Postma ● H. Marike Boezen ● Cornelia M. van Duijn ● Najaf Amin Received: 14 March 2017 / Revised: 6 November 2017 / Accepted: 19 December 2017 / Published online: 8 February 2018 © The Author(s) 2018. This article is published with open access Abstract Chronic obstructive pulmonary disease (COPD) is a major health burden in adults and cigarette smoking is considered the most important environmental risk factor of COPD. Chromosome 15q25.1 locus is associated with both COPD and smoking. Our study aims at understanding the mechanism underlying the association of chromosome 15q25.1 with COPD through epigenetic and transcriptional variation in a population-based setting. To assess if COPD-associated variants in 1234567890();,: 15q25.1 are methylation quantitative trait loci, epigenome-wide association analysis of four genetic variants, previously associated with COPD (P < 5 × 10−8) in the 15q25.1 locus (rs12914385:C>T-CHRNA3, rs8034191:T>C-HYKK, rs13180: C>T-IREB2 and rs8042238:C>T-IREB2), was performed in the Rotterdam study (n = 1489).
    [Show full text]